...ns National Zoo recently acquired 12,000 new anima...tional Zoo scientists in Puerto Ricoas part of an ...hreatened species. National Zoo scientists hope to...to their wild ocean habitat. , In August, Zoo Rep...rates Keeper Mike Henley traveled to Puerto Rico w...
..., Ph.D., and a team of national collaborators have...he National Institutes of Health (NIH) for their r...tive Substances and Psychosocial Stress. alAbsi i...cal Research Institute at the University of Minnes...among the first of 45 funded by the National Insti...
...nstitute of Transportation Studies (ITS-Davis) wil... Road to,Sustainability: From Research to Practice...ed for federal, state and local government,officia...sers, and,transportation specialists from nonprofi... highway and vehicle technologies; , Transit,s r...
Other Biology News:Smithsonian scientists working to save microscopic threatened species 2Mustafa al'Absi Ph.D. and national team awarded major NIH grant 2(Date:11/24/2009)... The New York investment bank KTA Capital,s ...reed an AU$6.7 mil convertible note private placem...e placement was arranged by KTA Capital as Neuren,... New York (PRWEB) November 23, 20... Capital, LLC ("KTA Capital") has announ...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--Sigma-AldrichCorporati...ferenceonTuesday,December1stat1:45PMGMTinLondon,7:...roadcastovertheInternetavailableat http://inve s..."Webcast"icontoaccessthisfile. ,, AboutSigma-...hTechnologycompany.Itschemicalandbiochemicalproduc...
(Date:11/24/2009)...lif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(...evelopingandcommercializingnovelpainmanagementther...dChiefExecutiveOfficer,isscheduledtopresentatthe21...ecember1-2,2009atTheNewYorkPalaceHotelinNewYork,Ne...nancialOfficer,willbeavailabletorespondtoquestions...
(Date:11/24/2009)...cacyendpointhasbeenmetforpatientswithadvanced-stag...Nov.24/PRNewswire-FirstCall/-AEternaZentarisInc.(N...maceuticalcompanyfocusedonendocrinetherapyandoncol...tudywithitstargetedcytotoxicpeptideconjugate,AEZS-...entendometrialcancer.Inapersonalizedhealthcareappr...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4...arch 11 Amicus Therapeutics (Nasdaq: FOLD ) tod...f Executive Officer John F. Crowley will be presen... Healthcare Conference. Mr. Crowley,s presentatio...30 a.m. Eastern Time. , , Individuals can listen ...n to the Investors section of the Amicus Therapeut...
...rch 11 Insmed Inc. (Nasdaq: INSM ), a developer...ls, today reported results for the quarter and ful...hlights , , , , Follow-on Biologics ...ive agreement with Merck & Co., Inc. whereby M...ts related to Insmed,s follow-on biologics platfor...
... 11 /PRNewswire-Asia/ -- Pharmaxis (ASX: PXS; NASD...pointed Praxis Pharmaceutical France SARL,as its F...nostic tool, Aridol. , Praxis Pharmaceutical i...uce a portfolio of respiratory specialist products...ll complete the reimbursement application for,Arid...
Other Biology Technology:Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results 2Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results 3Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results 4Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results 5Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results 6Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results 7Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results 8Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results 9Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results 10Pharmaxis Appoints French Distributor for Aridol(TM) 2Immunoprecipitation Starter Pack from GE Healthcare, formerly Amersham Biosciences
Prolong Gold Antifade Reagent from Invitrogen
GIBCO Modified Eagle Medium (MEM) (2X); liquid from Invitrogen
FliTrx Panning Kit from Invitrogen
Biology Products: